Roche the latest multinational to expand in China
This article was originally published in Scrip
Roche is building up its operations in China in line with moves by other European pharma multinationals to strengthen their presence in this fast-growing market. The Swiss group is building several new facilities and has set up a new regional partnering operation at its existing site in Shanghai.
You may also be interested in...
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.